ASO Author Reflections: Evaluation of Tumor Regression After Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma—How to Do It?

被引：0
作者：
Flavio Roberto Takeda
Francisco Tustumi
Ivan Cecconello
机构：
[1] University of São Paulo Medical School,Department of Gastroenterology, Digestive Surgery Division
来源：
Annals of Surgical Oncology | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1248 / 1249
页数：1
相关论文
共 17 条
  • [1] Van Hagen P(2012)Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med. 366 2074-2084
  • [2] Hulshof MC(2014)Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer Ann Surg. 260 807-813
  • [3] van Lanschot JJ(2017)Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial Lancet. 390 2461-2471
  • [4] Steyerberg EW(undefined)undefined undefined undefined undefined-undefined
  • [5] van Berge Henegouwen MI(undefined)undefined undefined undefined undefined-undefined
  • [6] Shapiro J(undefined)undefined undefined undefined undefined-undefined
  • [7] van Hagen P(undefined)undefined undefined undefined undefined-undefined
  • [8] Lingsma HF(undefined)undefined undefined undefined undefined-undefined
  • [9] Wijnhoven BP(undefined)undefined undefined undefined undefined-undefined
  • [10] Biermann K(undefined)undefined undefined undefined undefined-undefined
12